Waitemata Endoscopy
Waitemata Endoscopy is a private Auckland-based specialist practice operating two endoscopy clinics that deliver diagnostic and advanced therapeutic gastroenterology procedures to patients via GP/specialist referrals and direct self-referral.
- Company typePrivate
- Founded2005
- HeadquartersAuckland, New Zealand
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Waitemata Endoscopy does
Waitemata Endoscopy is a private medical practice operating two specialist endoscopy clinics in Auckland, New Zealand: a North Shore site at 212 Wairau Road (Wairau Valley) co-located with the Southern Cross North Harbour campus, and a West Auckland site at 53 Lincoln Road (Henderson) adjacent to Waitakere Hospital. Founded in 2005 and operating in partnership with Southern Cross Hospitals Limited, the practice delivers diagnostic endoscopy (gastroscopy, colonoscopy, flexible sigmoidoscopy, endoscopic ultrasound), therapeutic procedures (haemorrhoid banding/sclerotherapy), bowel cancer screening, and a broad suite of advanced therapeutic techniques including ESD, POEM, G-POEM, Z-POEM, FTRD, STER, ARMA, RFA, EMR, and APC. Services are delivered by a multi-disciplinary specialist team handling routine through to complex and tertiary gastroenterology cases, with AI-assisted report dictation (Heidi) used in the documentation workflow.
The customer base comprises individual patients accessed through two routes: GP and specialist referrals (supplemented by a monthly RNZCGP-accredited CME program that maintains referrer relationships), and self-referrals via a multi-page online booking and pre-assessment system. Revenue is generated per procedure on a pay-as-you-go basis, with insurance-funded and self-funded streams. Self-funded gastroscopy starts from NZD $2,000 and colonoscopy from NZD $3,000, with final cost varying by procedure combination, biopsies, pathology, sedation, and treating specialist. The practice reports a 70% polyp removal rate and claims one of the highest adenoma detection rates worldwide, positioning the offering around clinical quality and short wait times (standard procedures scheduled within 7 working days) rather than price competition.
The operating model is small and geographically concentrated: 12 employees across two clinic locations, no disclosed funding history, and ownership held privately as Waitemata Endoscopy Limited. Technology consists of standard endoscopy capital equipment (colonoscopes, gastroscopes, EUS probes) plus the Heidi AI documentation tool, with research activity in AI-assisted polyp detection. Growth signals are confined to incremental geographic and product-line expansion within Auckland, with the West Auckland clinic and the advanced therapeutic portfolio representing the principal recent developments.
Waitemata Endoscopy firmographics
Firmographics- Name
- Waitemata Endoscopy
- Legal name
- Waitemata Endoscopy Limited
- Website
- https://waitemataendoscopy.co.nz
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Waitemata Endoscopy is a private Auckland-based specialist practice operating two endoscopy clinics that deliver diagnostic and advanced therapeutic gastroenterology procedures to patients via GP/specialist referrals and direct self-referral.
- Ownership category
- akta.pro rank
Waitemata Endoscopy industry classification
Industry- Product category
- Diagnostic and Therapeutic Endoscopy Services
- NAICS
- Offices of Physicians (62111), Freestanding Ambulatory Surgical and Emergency Centers (621493), Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- General Gastroenterology (HLAKAEAA)
- akta.pro secondary industries
- Advanced Endoscopy (ERCP/EUS/Interventional) (HLAKAEAC), Endoscopy & GI Diagnostic Centers (HLAFAKAG), Endoscopy & GI Procedure Centers (HLAFAIAE)
Keywords
Where Waitemata Endoscopy is headquartered
LocationHeadquarters
- HQ city
- Auckland
- HQ country
- New Zealand
- HQ region
- Oceania
Offices2 records
Markets served
Waitemata Endoscopy business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Self-Funded Endoscopy Procedures: Patients without private health insurance can self-fund procedures. Self-funded gastroscopy starts from NZD $2,000 and colonoscopy from NZD $3,000. Final costs vary based on whether procedures are combined, whether biopsies or polyps are removed, additional treatment required, pathology fees, specialist performing the procedure, and individual medical needs.
- Insured Patient Procedures: The clinic accepts GP and specialist referrals and processes health insurance claims. Late or non-payment by medical insurers remains the patient's responsibility.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Self-funded gastroscopy starting price |
| Unit Pricing | Pay-as-you-go | Self-funded colonoscopy starting price |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Waitemata Endoscopy product offering
Product offeringCore offering
Waitemata Endoscopy operates a private endoscopy clinic in Auckland, New Zealand, providing diagnostic procedures (gastroscopy, colonoscopy, flexible sigmoidoscopy, endoscopic ultrasound) and advanced therapeutic endoscopy (ESD, POEM, G-POEM, Z-POEM, FTRD, STER, ARMA, RFA, EMR, APC) from two locations in partnership with Southern Cross Hospitals Limited. The clinic serves insured and self-funded patients, including a high-volume bowel cancer screening colonoscopy programme, and accepts GP/specialist referrals as well as self-referrals.
Product overview
Waitemata Endoscopy provides a comprehensive range of endoscopy services from two Auckland locations (North Shore and West Auckland). The core service portfolio includes diagnostic procedures (Gastroscopy, Colonoscopy, Flexible Sigmoidoscopy, Endoscopic Ultrasound), therapeutic treatments (Haemorrhoid Treatment, Bowel Cancer Screening), and sedation options. The centre also offers an extensive slate of advanced therapeutic endoscopy procedures including ESD, POEM, G-POEM, Z-POEM, FTRD, STER, ARMA, RFA, EMR, and APC Therapy. Services are available through GP/specialist referral or self-referral, with both insurance-funded and self-funded payment options starting from NZD $2,000 for gastroscopy and NZD $3,000 for colonoscopy.
Differentiator
Problem solved
Functional benefit
Products and services
- Gastroscopy Visual examination of the oesophagus, stomach and duodenum using a flexible tube with a camera, allowing biopsies and treatment during the same procedure. Used to assess reflux, cancer, ulcers, hernia, and coeliac disease.
- Colonoscopy Examination of the large bowel allowing biopsies, polyp removal and treatment of selected abnormalities, performed under sedation. Used to assess polyps, cancer, diverticuli, and haemorrhoids.
- Flexible Sigmoidoscopy Examination of the rectum and lower colon, with preparation typically simpler than full colonoscopy.
- Endoscopic Ultrasound (EUS) Combines endoscopy with ultrasound to examine the digestive tract and nearby organs such as the pancreas and bile ducts. Used to check for gallstones, pancreatic cancer, and biopsy of nodes/mass.
- Haemorrhoid Treatment Treatment options including banding and sclerotherapy injection for haemorrhoids, often performed alongside sigmoidoscopy or colonoscopy.
- Sedation Services Personalised sedation options including unsedated procedures, moderate sedation (midazolam and fentanyl), and propofol sedation administered by an anaesthetist.
- Self-Funded Endoscopy Private pay endoscopy services without requiring health insurance, with indicative pricing from NZD $2,000 for gastroscopy and NZD $3,000 for colonoscopy.
- Bowel Cancer Screening Colonoscopy-based screening programme for early polyp and cancer detection, with high adenoma detection rates and AI research involvement.
- Endoscopic Submucosal Dissection (ESD) Minimally invasive technique to remove early-stage cancers or pre-cancerous growths from the stomach, oesophagus, or colon in one piece.
- Per-oral Endoscopic Myotomy (POEM) Incision-free endoscopic treatment for achalasia and selected swallowing disorders, achieving over 90% symptom relief.
- Gastric Per-oral Endoscopic Myotomy (G-POEM) Endoscopic treatment for gastroparesis that cuts the pyloric sphincter to improve stomach emptying, showing up to 60% symptom improvement.
- Zenker's Per-oral Endoscopic Myotomy (Z-POEM) Treatment for Zenker's diverticulum that divides the obstructing cricopharyngeal muscle through a tunnel, with success rates over 90%.
- Full-Thickness Resection Device (FTRD) Specialised endoscopic tool for full-thickness removal of selected difficult bowel lesions or early cancers without conventional surgery.
- Submucosal Tunnelling Endoscopic Resection (STER) Technique for removing subepithelial tumours from the oesophagus, stomach, or small intestine through a tunnel created beneath the lining.
- Anti-Reflux Mucosal Ablation (ARMA) Endoscopic treatment for GORD in patients with persistent reflux despite medication, creating scar tissue to narrow the gastro-oesophageal junction.
- Radiofrequency Ablation (RFA) Heat-based treatment using HALO technology to remove abnormal Barrett's tissue, achieving complete elimination in 94% of dysplastic cases.
- Endoscopic Mucosal Resection (EMR) Technique to remove selected larger or flatter lesions from the gastrointestinal tract lining while avoiding conventional surgery.
- Argon Plasma Coagulation (APC) Therapy Non-contact thermal treatment using ionised argon gas for selected bleeding lesions, vascular lesions, or radiation-related rectal bleeding.
Quantifiable outcome
- 70% of patients have polyps removed during colonoscopy (48% tubular adenoma, 3% tubulovillous, 20% sessile serrated)
- +2 more outcomes
Companies that use Waitemata Endoscopy
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Waitemata Endoscopy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Waitemata Endoscopy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Southern Cross Hospitals LimitedcoreWaitemata Endoscopy operates in partnership with Southern Cross Hospitals Limited, providing comprehensive endoscopy services to patients Auckland-wide from their Northern Clinic at Southern Cross North Harbour campus on Auckland's North Shore and their new clinic at Lincoln Road, Henderson in West Auckland. Southern Cross is one of New Zealand's largest private surgical hospitals operators.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Waitemata Endoscopy competitors and assessment
Company assessmentBroad incumbents
- MercyAscot: Private hospital in Auckland operating across two sites, offering a wide range of services including endoscopy and gastroenterology. Comparable in target patient base and Auckland catchment, but with a broader general hospital scope rather than a specialist endoscopy focus.
- Southern Cross Hospitals: New Zealand's largest private surgical hospital operator and Waitemata Endoscopy's strategic partner. Provides endoscopy and gastroenterology services across multiple NZ sites as part of a broader surgical portfolio; relevant as a potential acquirer and as a competitive threat.
- Ramsay Health Care New Zealand: Subsidiary of ASX-listed Ramsay Health Care operating multiple private hospitals across NZ, including endoscopy and gastroenterology services. Comparable in service offering and private-pay model, but with substantially greater scale and a multi-specialty portfolio.
- Allevia Health (formerly Mercy Healthcare Auckland): Private healthcare group in Auckland operating multiple facilities including endoscopy and gastroenterology services. Comparable in Auckland catchment and private-pay model, but offers a broader multi-specialty portfolio rather than a focused endoscopy centre.
Direct peers
- Auckland Surgical Centre: Private day-stay surgical centre in Auckland providing a range of specialty procedures including endoscopy. Closely comparable in service model, target market, and Auckland geography; the most direct head-to-head peer for Waitemata's day-stay endoscopy volume.
Regional players
- Bowen Hospital: Private hospital in Wellington offering endoscopy, gastroenterology, and other surgical specialties. Provides a useful comparable for procedure mix and pricing, but is geographically separate from Waitemata's Auckland footprint.
- Wakefield Hospital: Private surgical and endoscopy hospital in Wellington, part of the broader NZ private hospital ecosystem. Comparable in clinical capability and service mix, but serves a different geographic market in the lower North Island.
- St George's Hospital: Private hospital in Christchurch offering endoscopy, gastroenterology, and a range of surgical services. Comparable as a South Island private provider with overlapping endoscopy service line, but operates in a different regional market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Waitemata Endoscopy social profiles
Digital presenceWaitemata Endoscopy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Waitemata Endoscopy leadership team
Management profileNumber of profiles
Waitemata Endoscopy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Waitemata Endoscopy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Waitemata Endoscopy
What does Waitemata Endoscopy do?
Waitemata Endoscopy operates a private endoscopy clinic in Auckland, New Zealand, providing diagnostic procedures (gastroscopy, colonoscopy, flexible sigmoidoscopy, endoscopic ultrasound) and advanced therapeutic endoscopy (ESD, POEM, G-POEM, Z-POEM, FTRD, STER, ARMA, RFA, EMR, APC) from two locations in partnership with Southern Cross Hospitals Limited. The clinic serves insured and self-funded patients, including a high-volume bowel cancer screening colonoscopy programme, and accepts GP/specialist referrals as well as self-referrals.
Is Waitemata Endoscopy a public or private company?
Waitemata Endoscopy is a private company. It is classified as unknown and is currently operating.
When was Waitemata Endoscopy founded?
Waitemata Endoscopy was founded in 2005. It employs 11 to 50 people.
Where is Waitemata Endoscopy based?
Waitemata Endoscopy is headquartered in Auckland, New Zealand, in the Oceania region.
How does Waitemata Endoscopy make money?
Two revenue lines are on record. Self-Funded Endoscopy Procedures are the primary driver. The others are insured Patient Procedures.
Who are Waitemata Endoscopy's main competitors?
Broad incumbents on record are MercyAscot, Southern Cross Hospitals, Ramsay Health Care New Zealand and Allevia Health (formerly Mercy Healthcare Auckland). Auckland Surgical Centre is listed as a direct peer. Regional players are Bowen Hospital, Wakefield Hospital and St George's Hospital.
Does Waitemata Endoscopy have an API?
No public API is recorded for Waitemata Endoscopy.
What industry is Waitemata Endoscopy in?
Waitemata Endoscopy's product category is Diagnostic and Therapeutic Endoscopy Services. Its primary akta.pro industry code is HLAKAEAA, General Gastroenterology, with a secondary code of HLAKAEAC, Advanced Endoscopy (ERCP/EUS/Interventional). Its NAICS code is 62111 and its SIC code is 8093.